Literature DB >> 24200267

Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women.

S R Jonnalagadda1, E Brown, B Lohman-Payne, D Wamalwa, C Farquhar, G C John-Stewart.   

Abstract

BACKGROUND: Data on the prognostic utility of interferon-gamma release assays (IGRAs) for active tuberculosis (TB) among human immunodeficiency virus 1 (HIV-1) infected individuals are limited.
METHODS: Samples from a perinatal cohort of HIV-1-infected women in Kenya, obtained during pregnancy, were tested using T-SPOT®.TB IGRAs to detect Mycobacterium tuberculosis-specific interferon-gamma (IFN-γ) responses. IFN-γ (cut-off values of >0, ≥6 and ≥10 spot-forming cells [SFC]/well) and CD4 cell count (cut-off values of <250 and <350 cells/l) were evaluated to determine sensitivity and specificity using a time-dependent receiver operating characteristic curve and positive predictive value (PPV) using the Kaplan Meier method for future TB within 1 year postpartum.
RESULTS: Of 327 women, 9 developed TB within 1 year postpartum (incidence rate 3.5/100 person-years of follow-up, 95%CI 1.66.7). IFN-γ ≥ 6 SFC/well was associated with an optimal trade-off between sensitivity (78%) and specificity (55%) and a PPV of 5.9%. In women with CD4 cell count of <250 cells/μl, the sensitivity and specificity of IFN- 6 SFC/well were respectively 89% and 63%, and the PPV was 19.2%.
CONCLUSION: Among HIV-1 infected women, IFN-γ response (≥6 SFC/well) during pregnancy lacked a high PPV for postpartum TB, but had higher sensitivity and PPV among immunosuppressed women (CD4 cell count of <250 cells/μl).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200267      PMCID: PMC4339676          DOI: 10.5588/ijtld.13.0239

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  25 in total

1.  Time-dependent ROC curves for censored survival data and a diagnostic marker.

Authors:  P J Heagerty; T Lumley; M S Pepe
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality.

Authors:  Phelgona A Otieno; Elizabeth R Brown; Dorothy A Mbori-Ngacha; Ruth W Nduati; Carey Farquhar; Elizabeth M Obimbo; Rose K Bosire; Sandy Emery; Julie Overbaugh; Barbra A Richardson; Grace C John-Stewart
Journal:  J Infect Dis       Date:  2006-12-13       Impact factor: 5.226

Review 3.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Authors:  Gerald H Mazurek; John Jereb; Phillip Lobue; Michael F Iademarco; Beverly Metchock; Andrew Vernon
Journal:  MMWR Recomm Rep       Date:  2005-12-16

5.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

6.  Predictive value of interferon-γ ELISPOT assay in HIV 1-infected patients in an intermediate tuberculosis-endemic area.

Authors:  Youn Jeong Kim; Sang Il Kim; Yang Ree Kim; Seong Heon Wie; Yeon Joon Park; Moon Won Kang
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-03       Impact factor: 2.205

7.  Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA.

Authors:  B Lange; M Vavra; W V Kern; D Wagner
Journal:  Int J Tuberc Lung Dis       Date:  2012-04       Impact factor: 2.373

8.  Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.

Authors:  Amita Gupta; Uma Nayak; Malathi Ram; Ramesh Bhosale; Sandesh Patil; Anita Basavraj; Arjun Kakrani; Sheeja Philip; Dipali Desai; Jayagowri Sastry; Robert C Bollinger
Journal:  Clin Infect Dis       Date:  2007-06-04       Impact factor: 9.079

9.  Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya.

Authors:  James N Kiarie; Barbra A Richardson; Dorothy Mbori-Ngacha; Ruth W Nduati; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2004-01-01       Impact factor: 3.731

Review 10.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

Authors:  Molebogeng X Rangaka; Katalin A Wilkinson; Judith R Glynn; Daphne Ling; Dick Menzies; Judith Mwansa-Kambafwile; Katherine Fielding; Robert J Wilkinson; Madhukar Pai
Journal:  Lancet Infect Dis       Date:  2011-08-16       Impact factor: 25.071

View more
  5 in total

1.  Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.

Authors:  Rose Molina; Kartik Venkatesh; Julianna Schantz-Dunn; Audra Meadows; Nawal Nour; Khady Diouf
Journal:  Matern Child Health J       Date:  2016-06

2.  Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.

Authors:  Jyoti S Mathad; Ramesh Bhosale; Usha Balasubramanian; Savita Kanade; Vidya Mave; Nishi Suryavanshi; Nikhil Gupte; Samir Joshi; Ajay Chandanwale; Kathryn M Dupnik; Vandana Kulkarni; Prasad Deshpande; Daniel W Fitzgerald; Amita Gupta
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

3.  Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India.

Authors:  Ramesh Bhosale; Mallika Alexander; Prasad Deshpande; Vandana Kulkarni; Nikhil Gupte; Amita Gupta; Jyoti Mathad
Journal:  Int J Infect Dis       Date:  2021-09-10       Impact factor: 3.623

Review 4.  Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population.

Authors:  Ying Yang; Hong-Jiao Wang; Wei-Lin Hu; Guan-Nan Bai; Chun-Zhen Hua
Journal:  Diagnostics (Basel)       Date:  2022-02-10

Review 5.  Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis.

Authors:  Hao Chen; Atsushi Nakagawa; Mikio Takamori; Seitarou Abe; Daisuke Ueno; Nobuyuki Horita; Seiya Kato; Nobuhiko Seki
Journal:  Infection       Date:  2022-03-06       Impact factor: 7.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.